Literature DB >> 1026343

Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation.

M Tubiana, E Malaise.   

Abstract

Available data on the parameters of cell kinetics in human solid tumors were reviewed. The mean duration of the cell cycle is 2 days; for G1 it is 1 day, for S it is 18 hours, and for G2 it is 6 hours. G1 has the greatest variability from tumor to tumor. The cell cycle and its phases are shorter in animal tumors but the relative durations and variabilities are similar. The labeling index (LI) and the growth fraction vary widely among human tumors, but they are correlated with the histologic type of the tumor. There is a correlation between the mean doubling time and the mean LI of the various histologic types of tumors. Cell loss is considerable in all human tumors, but it is more important in tumors with a high LI. Metastases and recurrence appear to have shorter doubling and cell cycle times than the primary tumor. There seems to be in patients with metastases a correlation between the survival and the growth rate of the metastases. There does not seem to be any correlation between the LI and the probability of dissemination. The depression of LI after irradiation is more important in human tumors than in experimental tumors and varies widely among human tumors. After irradiation, the depopulation seems more important in tumors with a high LI. The histologic groups of tumors with a high mean LI are on the average more radiosensitive and more sensitive to drugs.

Entities:  

Mesh:

Year:  1976        PMID: 1026343

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  9 in total

1.  A delay differential equation model for tumor growth.

Authors:  Minaya Villasana; Ami Radunskaya
Journal:  J Math Biol       Date:  2003-05-15       Impact factor: 2.259

Review 2.  Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors:  Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Too early to say, "no targeting of mitosis!".

Authors:  Katsumi Kitagawa
Journal:  Nat Rev Clin Oncol       Date:  2011-05-17       Impact factor: 66.675

4.  Dosage and the pharmacokinetics of cytotoxic drugs.

Authors:  J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

5.  A medulloblastoma showing an unusually long doubling time: reflection of its singular nature.

Authors:  Omer Doron; Jacob Zauberman; Ze'ev Feldman
Journal:  Childs Nerv Syst       Date:  2016-01-06       Impact factor: 1.475

6.  Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma.

Authors:  A Bonetti; M Zaninelli; S Rodella; A Molino; L Sperotto; Q Piubello; F Bonetti; R Nortilli; M Turazza; G L Cetto
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Radiation and heat sensitivity of cells from two slowly growing human melanoma xenografts.

Authors:  E K Rofstad; A Wahl; T Brustad
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

8.  Prognostic value of tumor growth kinetic parameters in prostate cancer patients.

Authors:  Gennady M Zharinov; Oleg A Bogomolov; Natalia Yu Neklasova; Grigory A Raskin; Irina V Chepurnaya; Sergey N Bugrov; Vladimir N Anisimov
Journal:  Oncotarget       Date:  2019-08-20

9.  A mammalianized synthetic nitroreductase gene for high-level expression.

Authors:  Maik Grohmann; Nils Paulmann; Sebastian Fleischhauer; Jakob Vowinckel; Josef Priller; Diego J Walther
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.